After Pacira Pharmaceuticals (NASDAQ: PCRX) issued preliminary results for the fourth quarter, its shares jumped 17.3% today.
After Pacira Pharmaceuticals (NASDAQ: PCRX) issued preliminary results for the fourth quarter, its shares jumped 17.3% today.